Trademark Overview
On Thursday, January 6, 2022, a trademark application was filed for IMMQUINT with the United States Patent and Trademark Office. The USPTO has given the IMMQUINT trademark a serial number of 97205454. The federal status of this trademark filing is ABANDONED - EXPRESS as of Monday, July 11, 2022. This trademark is owned by Pfizer Inc.. The IMMQUINT trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; Pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; Pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; Vaccines for human use